Splicing of mRNA (e.g., in SF3B1, SRSF2) also occurred in haematological tumours such as myelodysplastic syndrome (MDS) and chronic lymphocytic leukaemia (CLL) resulting in resistance to treatment [13]. The gene discussed is SRSF2; the disease is B-cell chronic lymphocytic leukemia.